Branched DNA assay

Branched DNA assay is a type of nucleic acid testing method that is used to measure the amount of specific RNA or DNA strands in a sample. This method is often used in clinical laboratories for the detection and quantification of viral RNA in patient samples, such as Hepatitis C and HIV.

History

The branched DNA assay was first developed in the 1980s by Chiron Corporation, a biotechnology company. The original version of the assay was used for the detection of Hepatitis B virus. Over the years, the technology has been improved and updated to increase its sensitivity and specificity.

Principle

The principle of the branched DNA assay is based on the use of branched DNA molecules as signal amplifiers. The assay involves the hybridization of target nucleic acids with specific probes, which are then bound to branched DNA molecules. The branched DNA molecules can bind to multiple signal-generating molecules, which allows for the amplification of the signal and the detection of the target nucleic acids.

Procedure

The procedure of the branched DNA assay involves several steps. First, the sample is prepared and the target nucleic acids are extracted. Then, the nucleic acids are hybridized with specific probes. The probes are designed to bind to specific sequences in the target nucleic acids. After the hybridization, the branched DNA molecules are added. These molecules bind to the probes and amplify the signal. Finally, the signal is detected and quantified.

Applications

The branched DNA assay is used in various applications in clinical laboratories. It is used for the detection and quantification of viral RNA in patient samples. This can be used for the diagnosis of viral infections, such as Hepatitis C and HIV. The assay is also used for the monitoring of viral load in patients undergoing antiviral therapy.

Advantages and Limitations

The main advantage of the branched DNA assay is its high sensitivity and specificity. The use of branched DNA molecules as signal amplifiers allows for the detection of low levels of target nucleic acids. However, the assay has some limitations. It requires specialized equipment and trained personnel. In addition, the assay can be affected by the presence of inhibitors in the sample.

   This article is a Biotechnology stub. You can help WikiMD by expanding it!

   This article is a medical stub. You can help WikiMD by expanding it!